LexDanaLexDanabeta
Inventor

OFIR MORENO

Inventor
US

Overview

4→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,329,739Isoflavonoid compounds and methods for the treatment of cancer202512,318,364Isoflavonoid compositions and methods for the treatment of cancer202511,723,893Isoflavonoid compositions and methods for the treatment of cancer202311,583,514Isoflavonoid compounds and methods for the treatment of cancer2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to MEI PHARMA INC (2)· patent assignee history
2023–2025Based in US· patent location history
2025Patents assigned to AARDVARK THERAPEUTICS INC (2)· patent assignee history
2025Patents assigned to AARDVARK THERAPEUTIC INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AARDVARK THERAPEUTICS INC22025
MEI PHARMA INC22023
AARDVARK THERAPEUTIC INC12025
Locations
LocationPatentsSpan
US42023–2025